Nioh 3 is the first game in the series to adopt an open-world approach, where you can explore pretty much wherever you like. There are some constraints to that, as each subregion within the game's ...

Altimmune closed a $75M direct offering to fund Phase 3 pemvidutide trials for MASH, leveraging recent positive Phase 2b data and FDA Breakthrough Therapy status. Pemvidutide’s dual GLP-1/glucagon ...

Trials aim to optimize frontline therapies for CLL, multiple myeloma, SLL, and pediatric acute leukemia/MDS, focusing on high-risk, treatment-naïve patients. Investigations include BTK inhibitors, CAR ...

A potential inflection point that Bausch Health hoped could diversify its portfolio has vanished with a pair of phase 3 failures for a new formulation of the company’s bread-and-butter Xifaxan—a ...

As The Bay park is in the midst of its October-long, three-year anniversary celebration of the opening of Phase 1, work on Phase 2 and planning for Phase 3 remains ongoing. With the Oct. 16 ...

Regeneron has reported a phase 3 win in generalized myasthenia gravis (gMG), positioning the pharma to file for FDA approval of its siRNA candidate in the increasingly competitive neuromuscular ...

Pharvaris, a late-stage biopharmaceutical company focused on developing oral bradykinin B2 receptor antagonists for bradykinin-mediated diseases like hereditary angioedema (HAE), has updated the ...

CHARLESTON, S.C. (WCIV) — A major new chapter in Charleston’s urban development is taking shape as the City’s Board of Architectural Review considers the conceptual plans for Phase 3 of the Courier ...

At a high-level side event during the 4th International Conference on Financing for Development (FfD4) in Seville, Spain, WTO Director-General Ngozi Okonjo-Iweala called for mobilizing strong global ...

A Phase 3 clinical trial testing the experimental daily oral treatment ralinepag in people with pulmonary arterial hypertension (PAH) has completed enrollment. The ADVANCE OUTCOMES trial (NCT03626688) ...

A single dose of a synthetic form of psilocybin known as COMP360 (Compass Pathways) is both statistically significant and clinically meaningful in reducing treatment-resistant depression (TRD) in a ...